Vericel (VCEL) Stock
Vericel (VCEL) closed at $57.88 on Nov 17, 2026; its Tenet Score is 61 of 100 against 340 Healthcare peers.
6 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $57.88
- Nov 17, 2026
- Market cap
- $2.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 91.4×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 28.95 – 59.75
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 61/100
- Solid · 340 Healthcare peers
Industry: Drugs
Vericel Corp scores 61/100. Solid. Strongest on financial health and growth, value is the soft spot, trading at 91× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ✓ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Lynch GARP
13F flows & insider trades land here.
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologou…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Supernus Inc.SUPN | 53 | $3.4B |
| Acadia Pharmaceuticals IncACAD | 65 | $3.2B |
| Bausch Health Companies IncBHC | 51 | $3.2B |
| Dyne Therapeutics IncDYN | 52 | $3.1B |
| Xeris Biopharma Holdings IncXERS | 48 | $3.1B |
| Adma Biologics IncADMA | 72 | $3.0B |
| Ideaya Biosciences IncIDYA | 57 | $2.9B |
| Denali Therapeutics IncDNLI | 54 | $2.9B |
| Xencor IncXNCR | 40 | $2.7B |
| HUTCHMED (China) LimitedHCM | 61 | $2.6B |
Common questions
What sector and industry is Vericel in?
Vericel is in the Healthcare sector and the Drugs industry.
What is Vericel's Tenet Score?
Vericel's Tenet Score is 61 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




